Why Invest in the Southeast? In sum, because the region’s dynamic and growing economy produces strong deal flow at reasonable valuations, and has historically produced higher returns for venture investors than other regions of the country. The Southeastern economy...Read More
About a year after it raised $12.5 million, it announced Thursday that it raised another $33 million, including from Eshelman Ventures, the investment fund founded byFred Eshelman, one of the most successful people in the Triangle pharmaceutical space.
Raleigh-based Salix Pharmaceuticals was officially acquired by Valeant Pharmaceuticals International for $158 per share, or about $10 billion in cash.
Please join us in beautiful Charleston, S.C. next November for the 17th Annual SEBIO Investor & Partnering Forum!
More details to come in early 2015